Zhonghua nei ke za zhi · 2008
[The application of combined detection of autoantibodies in primary Sjögren's syndrome].
Аннотация на английскомСтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
He Jing, Fang Wan, Li Zhan-Guo
Аннотация
OBJECTIVE: To compare the specificity and sensitivity of antibodies against SSA and SSB, anti-M3 receptor polypeptide antibodies, anti-alpha-fodrin (IgG) antibodies in primary Sjögren's syndrome (pSS).
METHODS: One hundred and ten pSS patients (mean age was 49.2 +/- 14. 8, mean disease duration was 5.6 +/- 4.6), 80 systemic lupus erythematosus (SLE) patients (mean age was 25.5 +/- 4.6, mean disease duration was 2.5 +/- 1.2) and 80 rheumatoid arthritis (RA) patients (mean age was 44.6 +/- 3.5, mean disease duration was 4.2 +/- 1.1) were studied. Enzyme-linked immunosorbent assay was used to measure these antibodies.
RESULTS: The seropositive rates of anti-SSA, anti-SSB antibodies, anti-M3 receptor polypeptide antibodies and anti-alpha-fodrin (IgG) antibodies were 45.5%, 30.9%,78.2% and 77.3%, respectively in pSS. They were much higher than those in RA and SLE patients (P < 0.05). Specificities of SSA, SSB antibodies, anti-M3 receptor antibodies and anti-alpha-fodrin IgG were 83.8%, 97.7%, 92.0% and 90.0% respectively. With the combination of these antibodies in the diagnosis of pSS, the sensitivity can be increased at least to 88.2% and the specificity was not decreased significantly.
CONCLUSION: Combination of these antibodies can significantly improve the sensitivity of these antibodies in the diagnosis of pSS. Anti-SSA and SSB antibodies, anti-M3 receptor antibodies and anti-alpha-fodrin (IgG) antibodies are specific antibodies for the diagnosis of pSS.
METHODS: One hundred and ten pSS patients (mean age was 49.2 +/- 14. 8, mean disease duration was 5.6 +/- 4.6), 80 systemic lupus erythematosus (SLE) patients (mean age was 25.5 +/- 4.6, mean disease duration was 2.5 +/- 1.2) and 80 rheumatoid arthritis (RA) patients (mean age was 44.6 +/- 3.5, mean disease duration was 4.2 +/- 1.1) were studied. Enzyme-linked immunosorbent assay was used to measure these antibodies.
RESULTS: The seropositive rates of anti-SSA, anti-SSB antibodies, anti-M3 receptor polypeptide antibodies and anti-alpha-fodrin (IgG) antibodies were 45.5%, 30.9%,78.2% and 77.3%, respectively in pSS. They were much higher than those in RA and SLE patients (P < 0.05). Specificities of SSA, SSB antibodies, anti-M3 receptor antibodies and anti-alpha-fodrin IgG were 83.8%, 97.7%, 92.0% and 90.0% respectively. With the combination of these antibodies in the diagnosis of pSS, the sensitivity can be increased at least to 88.2% and the specificity was not decreased significantly.
CONCLUSION: Combination of these antibodies can significantly improve the sensitivity of these antibodies in the diagnosis of pSS. Anti-SSA and SSB antibodies, anti-M3 receptor antibodies and anti-alpha-fodrin (IgG) antibodies are specific antibodies for the diagnosis of pSS.
Предметные рубрики MeSH
AdultAntibodies, Anti-IdiotypicAntibodies, AntinuclearArthritis, RheumatoidAutoantibodiesCarrier ProteinsEnzyme-Linked Immunosorbent AssayFemaleHumansLupus Erythematosus, SystemicMaleMicrofilament ProteinsMiddle AgedReceptor, Muscarinic M3Sensitivity and SpecificitySjogren's SyndromeYoung AdultSpectrin